Analysis of variance of the effect of TA-TMA on cost per day and total cost for patients who received allogeneic transplant
| . | Univariate model (n = 375) . | Multivariable model (n = 375) . | ||
|---|---|---|---|---|
| Factor . | P value . | Factors . | P value . | |
| Cost per day | TA-TMA | .434 | TA-TMA | .617 |
| HLA mismatch | .890 | |||
| Infection | .246 | |||
| Grade 3/4 GVHD | .014 | |||
| Total cost | TA-TMA | .002 | TA-TMA | .084 |
| HLA mismatch | .814 | |||
| Infection | .452 | |||
| Grade 3/4 GVHD | <.001 | |||
| . | Univariate model (n = 375) . | Multivariable model (n = 375) . | ||
|---|---|---|---|---|
| Factor . | P value . | Factors . | P value . | |
| Cost per day | TA-TMA | .434 | TA-TMA | .617 |
| HLA mismatch | .890 | |||
| Infection | .246 | |||
| Grade 3/4 GVHD | .014 | |||
| Total cost | TA-TMA | .002 | TA-TMA | .084 |
| HLA mismatch | .814 | |||
| Infection | .452 | |||
| Grade 3/4 GVHD | <.001 | |||
The bolded values are statistically significant.